defense · stock-purchase · committee-conflict
Rep. Rich McCormick Buys L3Harris Stock Ahead of 10% Decline
The Georgia Republican’s purchase of the defense contractor aligns with his committee roles but has so far yielded negative returns.
2026-07-22 — Richard Dean Dr Mccormick · LHX
Key facts
- Rep. Rich McCormick purchased between $1,001 and $15,000 of L3Harris Technologies stock on June 12, 2026.
- McCormick serves on the House Committee on Armed Services, which directly oversees the Department of Defense.
- The stock has declined roughly 10% since the purchase was executed.
- The purchase was executed as part of a 10-trade batch, suggesting routine portfolio rebalancing.
Rep. Richard Dean Dr McCormick (R-Ga.) recently re-entered a position in defense contractor L3Harris Technologies (LHX), highlighting the ongoing intersection between congressional oversight and personal portfolios.
On June 12, 2026, McCormick purchased between $1,001 and $15,000 of L3Harris stock. The transaction was disclosed on July 9, 2026, 27 days after execution. Under the STOCK Act, members of Congress are required to disclose their trades within 45 days, and all transaction values are reported in broad ranges rather than exact figures.
The timing of the buy has not proved immediately profitable. Since McCormick bought in at $307.79, L3Harris shares have slid roughly 10%. Our analysis scored the trade 33/100, noting a 7.2% drop by the time of compiling the report.
What makes the trade notable is McCormick's legislative footprint. He serves on the House Committee on Armed Services, which exercises direct policy and authorization oversight over the Department of Defense—L3Harris’s primary customer. Additionally, McCormick chairs the Investigations and Oversight subcommittee of the Committee on Science, Space, and Technology, providing a policy link to L3Harris's substantial Space & Mission Systems segment, which reported $2.99 billion in revenue for the first quarter of 2026 [2, 3].
This is not McCormick's first time trading L3Harris. Our analysis shows a pattern of swing-trading the defense stock; the Representative has traded the ticker five times since 2023, most recently selling shares in March 2026 before buying back in this June.
While the trade carries potential committee conflict, there is a strong alternative explanation: routine portfolio rebalancing. The L3Harris buy was executed on the same day as nine other trades, all in the identical $1,001 to $15,000 range. This batch included two other purchases (Abbott Laboratories and Intercontinental Exchange) alongside seven sales, suggesting programmatic adjustments of his holdings rather than a targeted play on defense policy.
L3Harris itself had a quiet period around the trade. While the company reported a record backlog in its Q1 earnings on April 30 [2, 3] and finalized agreements involving its Aerojet Rocketdyne subsidiary in mid-April, no fresh, unpriced catalysts were public at the time of McCormick's buy. Routine equity awards were later reported for corporate insiders on July 1.
For now, a seat on Armed Services is no guarantee of defense-sector gains.
Sources
- L3Harris 8-K Aerojet Rocketdyne Agreement — SEC EDGAR
- L3Harris Q1 2026 Earnings 8-K — SEC EDGAR
- L3Harris Q1 2026 Earnings Release Exhibit 99.1 — SEC EDGAR
- L3Harris Insider Form 4 Filings — SEC EDGAR